Tenax Therapeutics financials at a glance

+ Portfolio

The revenue of Tenax Therapeutics is reported as 0 billion Dollars in the fiscal year 2023. The earnings were -24.8 Dollars per share in 2023, which was 76.23 higher than 2021. And about -1.0E-5 billion Dollars are reported as free cash flow in the financials of Tenax Therapeutics 2023. No dividends were paid to the shareholders of the Tenax Therapeutics stock NasdaqCM:TENX in the financial year 2023.

$0.00M

Revenue

$-,600.80

Earnings Per Share

0.00%

Gross Margin %

$0.00M

Free Cash Flow

Revenue

0.00

Earnings Per Share

-,600.80

Gross Margin %

0.00

Free Cash Flow

0.00

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014	2011
Rev.	Revenue	N/A	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M	$0.05M	$0.03M	$0.32M
GM %	Gross Margin %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	$-0.49	$-,600.80	$-2,528.00	$-2,128.00	$-2,160.00	$-14,464.00	$-10,032.00	$-17,920.00	$-16,000.00	$-86,720.00	$-,275,200.00
Div.	Dividends	N/A	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
PR %	Payout Ratio %	0	0	0	0	0	0	0	0	0	0	0
Sha.	Shares	N/AM	0.28M	0.02M	12.62M	6.74M	3.02M	1.41M	1.41M	1.41M	1.41M	0.07M
OCF	Operating Cash Flow	N/A	$0.00M	$0.00M	$9.27M	$0.00M	$0.00M	$0.00M	$-15.87M	$-9.75M	$0.00M	$0.00M
FCF	Free Cash Flow	N/A	$0.00M	$0.00M	$-9.28M	$-7.56M	$-5.51M	$0.00M	$-15.87M	$-9.75M	$0.00M	$0.00M
FCFS	Free Cash Flow Per Share	$-0.49	$-8.17	$-0.53	$-1.25	$-1.22	$-3.52	$-8.61	$-11.29	$-9.57	$0.00	$0.00

Tenax Therapeutics financials at a glance

Financials

Discover